AbCellera Biologics Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

AbCellera Biologics Inc. reported Cash And Cash Equivalents At Carrying Value of $61.80 million for the year ending 2025.

  • AbCellera Biologics Inc. showed an increase of +11.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AbCellera Biologics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), AbCellera Biologics Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 89.6%.
  • Historical annual values: Fiscal year 2025: $61.80 million | Fiscal year 2024: $55.60 million | Fiscal year 2023: $133.32 million | Fiscal year 2022: $44.90 million | Fiscal year 2021: $8.20 million | Fiscal year 2020: $594.12 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: